Journals
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 29 of 29
2021-05-28 [p.999]
— by Mr. Alghabra (Minister of Transport) — Document from the government in response to the order adopted by the House on Tuesday, May 25, 2021. — Sessional Paper No. 8530-432-5.
2021-05-25 [p.960]
By unanimous consent, Mr. Gerretsen (Kingston and the Islands) laid upon the table, — Document entitled "Share of people who received at least one dose of COVID-19 vaccine, May 24, 2021". — Sessional Paper No. 8530-432-4.
2021-05-10 [p.917]
Pursuant to Standing Order 39(7), Mr. Lamoureux (Parliamentary Secretary to the President of the Queen’s Privy Council for Canada and Minister of Intergovernmental Affairs and to the Leader of the Government in the House of Commons) presented the returns to the following questions made into orders for return:
Q-575 — Ms. Rood (Lambton—Kent—Middlesex) — With regard to providing the COVID-19 vaccine to Canadian Armed Forces (CAF) members serving abroad: (a) what specific measures are in place to ensure that CAF members serving abroad receive the vaccine; and (b) what is the timeline for when the (i) first dose, (ii) second dose (if applicable), of the vaccine has been or will be administered, broken down by the name of vaccine manufacturer (Pfizer, Moderna, etc.) and the country where CAF members are serving in? — Sessional Paper No. 8555-432-575.
2021-05-10 [p.918]
Q-577 — Ms. Rood (Lambton—Kent—Middlesex) — With regard to the national vaccine management information technology platform (NVMIP): (a) what are the functionalities of the NVMIP; (b) which provinces and territories are currently using the NVMIP; and (c) what are the details the government has related to the usage of NVMIP by the provinces and territories, including (i) the date each province or territory began to use the NVMIP, (ii) which functionalities of NVMIP are each province or territory is using, (iii) the date each province or territory began using each of NVMIP's functionalities? — Sessional Paper No. 8555-432-577.
2021-05-10 [p.919]
Q-582 — Mr. Saroya (Markham—Unionville) — With regard to the government's decision to extend the interval between certain COVID-19 vaccines by up to 105 days: (a) what assessment has the government made on the impact of this decision of those who are suffering from cancer; and (b) what is the government's response to concerns raised by a study from King's College London and the Francis Crick Institute, which found that delays in administering the second dose of more than 21 days leave cancer patients vulnerable to COVID-19? — Sessional Paper No. 8555-432-582.
2021-05-05 [p.895]
Pursuant to Standing Order 32(2), Mr. Lamoureux (Parliamentary Secretary to the President of the Queen’s Privy Council for Canada and Minister of Intergovernmental Affairs and to the Leader of the Government in the House of Commons) laid upon the table, — Government responses, pursuant to Standing Order 36(8), to the following petitions:
— Nos. 432-00681 and 432-00694 concerning natural resources and energy;
— No. 432-00683 concerning Indigenous affairs;
— Nos. 432-00684, 432-00686, 432-00688, 432-00695 and 432-00697 concerning justice;
— Nos. 432-00685, 432-00687, 432-00689 and 432-00693 concerning foreign affairs;
— No. 432-00690 concerning human diseases;
— Nos. 432-00691, 432-00696 and 432-00699 concerning health;
— No. 432-00692 concerning the environment;
— No. 432-00698 concerning public safety.
Application processArmy of the Guardians of the Islamic Rev ...British ColumbiaCannabisCapacity of consent for careChinaCivil and human rightsCoalCompensationConsentContaminated sites ...Show all topics
2021-05-03 [p.878]
Pursuant to order made Monday, January 25, 2021, the House proceeded to the taking of the deferred recorded division on the motion of Mr. O'Toole (Durham), seconded by Ms. Rempel Garner (Calgary Nose Hill), — That, given that,
(i) only 2.7% of Canadians are fully vaccinated against COVID-19,
(ii) the federal government did not deliver adequate vaccine supply in January and February 2021,
(iii) the government extended the recommended interval for the second vaccine dose to four months against the recommendations of vaccine manufacturers,
(iv) Canadians are facing increased restrictions and lockdowns in multiple provinces from British Columbia to Nova Scotia,
the House call on the government to ensure that every Canadian adult has access to a vaccine by the May long weekend.
The question was put on the motion and it was negatived on the following division:
(Division No. 104 -- Vote no 104) - View vote details.
YEAS: 119, NAYS: 208
2021-04-29 [p.861]
The order was read for the consideration of the business of supply.
Mr. O'Toole (Durham), seconded by Ms. Rempel Garner (Calgary Nose Hill), moved, — That, given that,
(i) only 2.7% of Canadians are fully vaccinated against COVID-19,
(ii) the federal government did not deliver adequate vaccine supply in January and February 2021,
(iii) the government extended the recommended interval for the second vaccine dose to four months against the recommendations of vaccine manufacturers,
(iv) Canadians are facing increased restrictions and lockdowns in multiple provinces from British Columbia to Nova Scotia,
the House call on the government to ensure that every Canadian adult has access to a vaccine by the May long weekend.
Debate arose thereon.
2021-04-29 [p.862]
The House resumed consideration of the motion of Mr. O'Toole (Durham), seconded by Ms. Rempel Garner (Calgary Nose Hill), in relation to the business of supply.
The debate continued.
2021-04-29 [p.862]
The question was put on the motion and, pursuant to order made Monday, January 25, 2021, the recorded division was deferred until Monday, May 3, 2021, at the expiry of the time provided for Oral Questions.
2021-04-26 [p.827]
Q-513 — Ms. Rempel Garner (Calgary Nose Hill) — With regard to the National Advisory Committee on Immunization (NACI) and Health Canada respectively: (a) what scientific evidence, expert opinions, and other factors went into the decision to extend the dosing schedule up to four months between doses of the COVID-19 vaccines; and (b) what is the summary of the minutes of each meeting the NACI had in which dosing timelines were discussed? — Sessional Paper No. 8555-432-513.
2021-04-21 [p.800]
Q-470 — Mr. Kitchen (Souris-Moose Mountain) — With regard to the acquisition of freezers required to transport and store the Pfizer COVID-19 vaccine: (a) how many freezers were purchased; (b) what is the total cost of purchasing the freezers; (c) what is the cost per unit of freezers purchased, broken down by type of unit; (d) how many of each type of unit were purchased; (e) how many of each type of unit purchased are in each (i) province or territory, (ii) local health unit district; (f) how many of each type of unit were purchased for the purpose of transporting the vaccine; (g) how many freezers were rented; (h) what is the total cost of renting the freezers; (i) what is cost per unit of freezers rented, broken down by type of unit; (j) what are the estimated costs of (i) transporting, (ii) maintaining the freezers, broken down by type of expense; and (k) what are the details of all contracts over $1,000 related to the purchase, acquisition, maintenance, or transportation of the freezers, including (i) the vendor, (ii) the amount, (iii) the description of goods or services, including the quantity, (iv) whether the contract was sole-sourced or awarded through a competitive biding process? — Sessional Paper No. 8555-432-470.
2021-04-14 [p.767]
The notice of motion for the production of papers P-2 was called pursuant to Standing Order 97(1) and was transferred by the clerk to “Notices of Motions (Papers)”.
2021-03-22 [p.662]
— by Mr. Sloan (Hastings—Lennox and Addington), one concerning human diseases (No. 432-00690);
2021-01-26 [p.464]
Pursuant to Standing Order 52(10), the House proceeded to the consideration of a motion to adjourn the House for the purpose of discussing an important matter requiring urgent consideration, namely, the COVID-19 vaccine.
Mr. O’Toole (Durham), seconded by Ms. Rempel Garner (Calgary Nose Hill), moved, — That this House do now adjourn.
Debate arose thereon.
At midnight, the Speaker declared the motion adopted.
2021-01-25 [p.446]
Q-292 — Ms. Rempel Garner (Calgary Nose Hill) — With regard to the Prime Minister's announcement in May 2020 of an agreement with CanSino Biologics Inc. (CanSinoBIO) in relation to the development of a potential COVID-19 vaccine: (a) what were the original details of the agreement, as understood by the government in May 2020; (b) on what date did the government first become aware that the agreement would not proceed as planned; (c) on what date did the government become aware that shipments of Ad5-nCoV were being blocked by the Chinese government; (d) what reason, if any, did the Chinese government provide to the government for blocking the shipment; (e) has the government transferred any money or any type of expenditures to CanSinoBIO since January 1, 2020, and, if so, what is the total amount sent, broken down by date of transfer; (f) what are the details of any contracts signed with CanSinoBIO since January 1, 2020, including the (i) amount, (ii) original value, (iii) final value, (iv) date the contract was signed, (v) description of goods or services, including volume; (g) was the National Security and Intelligence Advisor to the Prime Minister advised of the terms agreement prior to the Prime Minister's announcement, and, if so, did he approve of the agreement; (h) was the Department of National Defence or the Canadian Security Intelligence Service informed of the details of the agreement prior to the Prime Minister's announcement, and, if so, did they raise any concerns with the Office of the Prime Minister or the Privy Council Office; and (i) what were the results of any security analysis conducted in relation to CanSinoBIO? — Sessional Paper No. 8555-432-292.
2021-01-25 [p.453]
Q-321 — Mr. Dowdall (Simcoe—Grey) — With regard to the government's decision not to use PnuVax for domestic vaccine production: (a) why did the government decide not to invest in the PnuVax facility so that it could produce vaccines; (b) did the government have any communication with PnuVax about the possibility of vaccine production since March 13, 2020, and, if so, what are the details of each communication; (c) did the government discuss the possibility of a Strategic Innovation Fund investment with PnuVax, and, if not, why not; and (d) has the government received any applications for funding or financial assistance from PnuVax since March 13, 2020, and, if so, what are the details, including the (i) date of application, (ii) government program, (iii) amount applied for, (iv) reason the application was denied, if applicable? — Sessional Paper No. 8555-432-321.
2021-01-25 [p.460]
Pursuant to Standing Order 52, Mr. O’Toole (Durham) asked leave to move the adjournment of the House for the purpose of discussing a specific and important matter requiring urgent consideration, namely, the COVID-19 vaccine.
The Speaker decided that the matter was proper to be discussed and, pursuant to Standing Order 52(9), directed that it be considered on Tuesday, January 26, 2021, at the ordinary hour of daily adjournment.
2020-12-16 [p.417]
— by Ms. Hajdu (Minister of Health) — Document entitled "Canada's COVID-19 Immunization Plan: Saving Lives and Livelihoods", pursuant to order made Monday, December 7, 2020. — Sessional Paper No. 8530-432-2.
2020-12-07 [p.363]
The order was read for the consideration of the business of supply.
Mr. Poilievre (Carleton), seconded by Mr. Cooper (St. Albert—Edmonton), moved, — That, given that,
(i) Canadian businesses are in distress and need help to survive as a rapid testing and vaccination plan rolls out,
(ii) according to the Canadian Federation of Independent Business, 46% are worried about the survival of their business,
(iii) the federal government must support employment by removing barriers to job creation, such as taxes and regulation,
the House call on the government to:
(a) provide complete details on the Highly Affected Sectors Credit Availability Program by December 16, 2020, including criteria, when businesses can apply, which sectors are eligible, when repayment will be required, and how much forgiveness will be offered;
(b) fix the Large Employer Emergency Financing Facility by reducing restrictions and amending the interest rate schedule;
(c) postpone the increase of the Canada Pension Plan payroll taxes planned for January 1, 2021; and
(d) postpone the increase of the carbon tax and the alcohol escalator tax planned for 2021.
Debate arose thereon.
2020-12-07 [p.364]
By unanimous consent, it was ordered, — That, notwithstanding any standing order, special order or usual practice of the House, the deferred recorded division on the opposition motion standing in the name of the member for Durham, currently scheduled at the expiry of the time provided for Oral Questions today, be further deferred to the conclusion of debate on motions relating to the Main Estimates later today.
2020-12-07 [p.364]
Pursuant to Standing Order 32(2), Mr. Lamoureux (Parliamentary Secretary to the President of the Queen’s Privy Council for Canada and to the Leader of the Government in the House of Commons) laid upon the table, — Government responses, pursuant to Standing Order 36(8), to the following petitions:
— No. 432-00142 concerning foreign affairs;
— No. 432-00143 concerning justice;
— No. 432-00144 concerning social affairs and equality;
— No. 432-00145 concerning human diseases;
— No. 432-00146 concerning fisheries;
— Nos. 432-00147 and 432-00148 concerning consumer protection;
— No. 432-00149 concerning business and trade;
— No. 432-00150 concerning the environment;
— No. 432-00151 concerning information and privacy.
2020-12-07 [p.373]
Pursuant to order made earlier today, the House proceeded to the taking of the deferred recorded division on the motion of Mr. O'Toole (Durham), seconded by Ms. Rempel Garner (Calgary Nose Hill), — That, given that a vaccine represents an opportunity to turn the corner of the COVID-19 pandemic and that the successful deployment of a vaccine is essential to the health, safety, and economic security of every Canadian, the House call upon the government to table, electronically, pursuant to Standing Order 32(1), by Wednesday, December 16, 2020, a status update on:
(a) how each type of vaccine will be safely delivered to Canada, stored, and distributed to Canadians;
(b) the date on which each vaccine type will first be deployed in Canada and the rate of vaccinations anticipated by month;
(c) any intended federal guidance with respect to the deployment of the vaccine by priority group, such as front-line health workers and seniors; and
(d) the plan for distribution of the vaccine to Indigenous communities, members of the Canadian Armed Forces, and veterans.
The question was put on the motion and it was agreed to on the following division:
(Division No. 28 -- Vote no 28) - View vote details.
YEAS: 329, NAYS: 0
2020-12-03 [p.348]
The order was read for the consideration of the business of supply.
Mr. O'Toole (Durham), seconded by Ms. Rempel Garner (Calgary Nose Hill), moved, — That, given that a vaccine represents an opportunity to turn the corner of the COVID-19 pandemic and that the successful deployment of a vaccine is essential to the health, safety, and economic security of every Canadian, the House call upon the government to table, electronically, pursuant to Standing Order 32(1), by Wednesday, December 16, 2020, a status update on:
(a) how each type of vaccine will be safely delivered to Canada, stored, and distributed to Canadians;
(b) the date on which each vaccine type will first be deployed in Canada and the rate of vaccinations anticipated by month;
(c) any intended federal guidance with respect to the deployment of the vaccine by priority group, such as front-line health workers and seniors; and
(d) the plan for distribution of the vaccine to Indigenous communities, members of the Canadian Armed Forces, and veterans.
Debate arose thereon.
2020-12-03 [p.352]
The House resumed consideration of the motion of Mr. O'Toole (Durham), seconded by Ms. Rempel Garner (Calgary Nose Hill), in relation to the business of supply.
The debate continued.
2020-12-03 [p.352]
The question was put on the motion and, pursuant to order made Wednesday, September 23, 2020, the recorded division was deferred until Monday, December 7, 2020, at the expiry of the time provided for Oral Questions.
2020-11-20 [p.295]
Pursuant to Standing Order 39(7), Mr. Lamoureux (Parliamentary Secretary to the President of the Queen’s Privy Council for Canada and to the Leader of the Government in the House of Commons) presented the returns to the following questions made into orders for return:
Q-116 — Mr. Tochor (Saskatoon—University) — With regard to the government’s approach to influenza immunization, also known as the flu shot or flu vaccine: (a) how many doses of the flu shot has the government procured or arranged for the 2020-21 flu season; (b) when are all the doses expected to be available and what is the expected timeline regarding how many doses will be available each month; (c) what are the details of any related procurement agreements or arrangements, including (i) date the agreement was signed, (ii) vendor, (iii) amount of doses, (iv) delivery date, (v) financial terms; (d) how many flu shot doses does the government project will be needed for the 2020-21 flu season; and (e) how many flu shot doses does the government project will be available for Canadians by (i) November 30, 2020, (ii) December 31, 2020? — Sessional Paper No. 8555-432-116.
2020-10-22 [p.161]
— by Mr. Powlowski (Thunder Bay—Rainy River), one concerning human diseases (No. 432-00145).
2020-09-24 [p.11]
Pursuant to Standing Order 32(2), Mr. Lamoureux (Parliamentary Secretary to the President of the Queen’s Privy Council for Canada and to the Leader of the Government in the House of Commons) laid upon the table, — Government responses, pursuant to Standing Order 36(8), to the following petitions:
— Nos. 431-00237, 431-00250, 431-00253, 431-00296, 431-00301 and 431-00303 concerning foreign affairs;
— Nos. 431-00238, 431-00242, 431-00244, 431-00245, 431-00247, 431-00273, 431-00283, 431-00285 and 431-00288 concerning the environment;
— No. 431-00239 concerning agriculture;
— Nos. 431-00240, 431-00241, 431-00243, 431-00246, 431-00251, 431-00258, 431-00259, 431-00260, 431-00265, 431-00268, 431-00271, 431-00279, 431-00280, 431-00281, 431-00292, 431-00293, 431-00297 and 431-00298 concerning justice;
— Nos. 431-00248, 431-00255, 431-00269, 431-00275, 431-00299 and 431-00300 concerning social affairs and equality;
— Nos. 431-00249, 431-00262 and 431-00287 concerning Indigenous affairs;
— Nos. 431-00252, 431-00263, 431-00290 and 431-00294 concerning health;
— Nos. 431-00254, 431-00256, 431-00274 and 431-00302 concerning natural resources and energy;
— Nos. 431-00257, 431-00267, 431-00272 and 431-00291 concerning the democratic process;
— Nos. 431-00261 and 431-00284 concerning fisheries;
— No. 431-00264 concerning culture and heritage;
— No. 431-00266 concerning civil and human rights;
— No. 431-00270 concerning media and telecommunications;
— No. 431-00276 concerning citizenship and immigration;
— No. 431-00277 concerning animals;
— No. 431-00278 concerning infrastructure;
— Nos. 431-00282 and 431-00286 concerning transportation;
— No. 431-00289 concerning the correctional system;
— No. 431-00295 concerning government services and administration.
AbortionAéroport Montréal Saint-Hubert LongueuilAir trafficAir transportationAnimal rights and welfareApplication processArtistsAsylumBeesBituminous sandsBorders ...Show all topics
Results: 1 - 29 of 29

Export As: XML CSV RSS

For more data options, please see Open Data